NEW YORK (GenomeWeb) – The Australian state of New South Wales said today it will invest A$24 million (US$22.4 million) over four years to create a medical genomics research program that will be led by the Garvan Institute of Medical Research in Sydney.

The NSW Government said today it has provided A$6 million from its 2014-2015 budget to launch this initiative, called the Sydney Genomic Collaborative Program, and at the same time announced more than A$90 million for medical research and development programs that includes support for other genomics projects.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.